TY  - JOUR
PY  - 2024//
TI  - Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: a retrospective cohort study
JO  - Drug and alcohol dependence
A1  - Krawczyk, Noa
A1  - Lim, Sungwoo
A1  - Cherian, Teena
A1  - Goldfeld, Keith S.
A1  - Katyal, Monica
A1  - Rivera, Bianca D.
A1  - McDonald, Ryan
A1  - Khan, Maria
A1  - Wiewel, Ellen
A1  - Braunstein, Sarah
A1  - Murphy, Sean M.
A1  - Jalali, Ali
A1  - Jeng, Philip J.
A1  - Kutscher, Eric
A1  - Khatri, Utsha G.
A1  - Rosner, Zachary
A1  - Vail, William L.
A1  - Macdonald, Ross
A1  - Lee, Joshua D.
SP  - e111377
EP  - e111377
VL  - 261
IS  - 
N2  - BACKGROUND: Offering medications for opioid use disorder (MOUD) in carceral settings significantly reduces overdose. However, it is unknown to what extent individuals in jails continue MOUD once they leave incarceration. We aimed to assess the relationship between in-jail MOUD and MOUD continuity in the month following release. <br><br>METHODS: We conducted a retrospective cohort study of linked NYC jail-based electronic health records and community Medicaid OUD treatment claims for individuals with OUD discharged from jail between 2011 and 2017. We compared receipt of MOUD within 30 days of release, among those with and without MOUD at release from jail. We tested for effect modification based on MOUD receipt prior to incarceration and assessed factors associated with treatment discontinuation. <br><br>RESULTS: Of 28,298 eligible incarcerations, 52.8 % received MOUD at release. 30 % of incarcerations with MOUD at release received community-based MOUD within 30 days, compared to 7 % of incarcerations without MOUD (Risk Ratio: 2.62 (2.44-2.82)). Most (69 %) with MOUD claims prior to incarceration who received in-jail MOUD continued treatment in the community, compared to 9 % of those without prior MOUD. Those who received methadone (vs. buprenorphine), were younger, Non-Hispanic Black and with no history of MOUD were less likely to continue MOUD following release. <br><br>CONCLUSIONS: MOUD maintenance in jail is strongly associated with MOUD continuity upon release. Still, findings highlight a gap in treatment continuity upon-reentry, especially among those who initiate MOUD in jail. In the wake of worsening overdose deaths and troubling disparities, improving MOUD continuity among this population remains an urgent priority.<p />  <p>Language: en</p>
LA  - en
SN  - 0376-8716
UR  - http://dx.doi.org/10.1016/j.drugalcdep.2024.111377
ID  - ref1
ER  -